| Date | Time | Source | Headline | Symbol | Company |
| 02/25/2014 | 7:40AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/25/2014 | 7:35AM | Business Wire | ARIAD Reports 2013 Financial Results and Outlines Key Objectives for 2014 | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/24/2014 | 4:54PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/24/2014 | 4:54PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/24/2014 | 7:35AM | Business Wire | ARIAD to Present at the Cowen and Company 34th Annual Health Care Conference | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/21/2014 | 5:31PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/21/2014 | 12:22PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/21/2014 | 7:35AM | Business Wire | ARIAD Expands Its Board of Directors with Appointment of Alexander J. Denner, Ph.D. of Sarissa Capital Management | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/19/2014 | 7:35AM | Business Wire | ARIAD to Present at the RBC Capital Markets Healthcare Conference | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/11/2014 | 9:15AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/10/2014 | 7:35AM | Business Wire | ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014 | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/05/2014 | 7:35AM | Business Wire | ARIAD to Present at the Leerink Swann Global Healthcare Conference | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/05/2014 | 6:02AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/28/2014 | 7:35AM | Business Wire | ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/17/2014 | 7:35AM | Business Wire | ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemi... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/14/2014 | 7:35AM | Business Wire | ARIAD & Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Co... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/14/2014 | 7:00AM | InvestorsHub NewsWire | Data Analysis Pre-Market: Peregrine Pharmaceuticals, American Airlines, Growlife, and Ariad Pharmaceuticals | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/13/2014 | 7:30AM | Business Wire | Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/13/2014 | 7:29AM | Zacks | Is A Short Squeeze Ahead for Ariad Pharmaceuticals, Inc. (ARIA)? - Tale of the Tape | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/02/2014 | 7:35AM | Business Wire | ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 12/23/2013 | 12:01PM | Business Wire | ARIAD annuncia la ripresa, negli Stati Uniti, della commercializzazione e distribuzione di Iclusig (ponatinib) per la leucemi... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 12/23/2013 | 7:54AM | Business Wire | ARIAD meldet Wiederaufnahme der Vermarktung und des kommerziellen Vertriebs von Iclusig ™(ponatinib) bei therapierefraktär... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 12/23/2013 | 2:00AM | Business Wire | ARIAD annonce la reprise de la commercialisation et de la distribution d'Iclusig (ponatinib) pour le traitement des leucémie... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 12/20/2013 | 10:10AM | Business Wire | ARIAD Announces U.S. Resumption of Marketing & Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Posi... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 12/06/2013 | 8:00PM | PR Newswire (US) | Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 12/05/2013 | 6:11PM | PR Newswire (US) | UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Director... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 12/03/2013 | 7:35AM | Business Wire | ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 12/02/2013 | 4:20PM | Marketwired | UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. & Its Board of Directors ... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 11/22/2013 | 1:48PM | Business Wire | ARIAD annonce que l'Agence européenne des médicaments a émis un avis favorable sur la disponibilité permanente de l'Iclus... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 11/22/2013 | 1:40PM | Business Wire | ARIAD gibt bekannt, dass die Europäische Arzneimittelagentur eine positive Stellungnahme zur kontinuierlichen Verfügbarkeit... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |